Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease

Daewoong Pharmaceutical Co. LTD.1,000 enrolled

Overview

Prescription and Persistence of Antithrombotic agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients with MCA(Middle Cerebral Artery) Disease.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

MCA - Middle Cerebral Artery Dissection

Interventions

ClopidogrelDRUG

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 19 years later, men and women Exclusion Criteria: * Subject who is judged to be ineligible by investigator

Locations (1)

SNUBH

Seoul, South Korea

RECRUITING

Outcomes

Primary Outcomes

Prescription status of Antithrombotic Agents

Time frame: at 12 months after baseline(onset)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.